Loading clinical trials...
Loading clinical trials...
TRYHARD: A Phase II, Randomized, Double Blind, Placebo-Controlled Study of Lapatinib (Tykerb®) for Non-HPV Locally Advanced Head and Neck Cancer With Concurrent Chemoradiation
Conditions
Interventions
IMRT
Cisplatin
+2 more
Locations
16
United States
University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
University of California, San Diego
La Jolla, California, United States
Sutter General Hospital
Sacramento, California, United States
University of California San Francisco
San Francisco, California, United States
Yale University
New Haven, Connecticut, United States
Emory University
Atlanta, Georgia, United States
Start Date
March 15, 2013
Primary Completion Date
December 1, 2020
Completion Date
September 21, 2022
Last Updated
October 17, 2023
Lead Sponsor
Radiation Therapy Oncology Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions